ONO Enters into a University-Wide, Research Alliance Agreeme

OSAKA, Japan, March 11, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University (Cambridge, MA, USA; "Harvard") aiming at validating novel therapeutic targets. In this alliance, as part of our ongoing open innovation initiative to collaborate...

Related Keywords

United States , Japan , Cambridge , Cambridgeshire , United Kingdom , Osaka , Gyo Sagara , Toichi Takino , Isaac Kohlberg , Harvard Gridand , Harvard University Cambridge , Harvard University , Harvard University Office Of Technology Development , Technology Development , Prnewswire Ono Pharmaceutical Co Ltd , Discovery Research At Ono , Sustainability Translational Fund , Harvard Office Of Technology Development , Senior Executive Officer , Executive Director , Vivian Berlin , Harvard Medical School , Senior Associate Provost , Chief Technology Development Officer , Biomedical Accelerator , Sustainability Translational ,